Collaborators. GG. Global, regional, and national burden of gout, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol. 2024;6:e507–e517.
Yanai H, Adachi H, Hakoshima M, Katsuyama H. Molecular biological and clinical understanding of the pathophysiology and treatments of hyperuricemia and its association with metabolic syndrome, cardiovascular diseases and chronic kidney disease. Int J Mol Sci. 2021;22:9221.
Mei Y, Dong B, Geng Z, Xu L. Excess uric acid induces gouty nephropathy through crystal formation: a review of recent insights. Front Endocrinol. 2022;13:911968.
Dehlin M, Jacobsson L, Roddy E. Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors. Nat Rev Rheumatol. 2020;16:380–90.
Han T, Chen W, Qiu X, Wang W. Epidemiology of gout - Global burden of disease research from 1990 to 2019 and future trend predictions. Ther Adv Endocrinol Metab. 2024;15:20420188241227295.
Article PubMed PubMed Central Google Scholar
He Q, Mok TN, Sin TH, Yin J, Li S, Yin Y, et al. Global, regional, and national prevalence of gout from 1990 to 2019: age-period-cohort analysis with future burden prediction. JMIR Public Health Surveill. 2023;9:e45943.
Article PubMed PubMed Central Google Scholar
Topless RKG, Major TJ, Florez JC, Hirschhorn JN, Cadzow M, Dalbeth N, et al. The comparative effect of exposure to various risk factors on the risk of hyperuricaemia: diet has a weak causal effect. Arthritis Res Ther. 2021;23:75.
Article CAS PubMed PubMed Central Google Scholar
Chi X, Zhang H, Zhang S, Ma K. Chinese herbal medicine for gout: a review of the clinical evidence and pharmacological mechanisms. Chin Med. 2020;15:17.
Article CAS PubMed PubMed Central Google Scholar
Liang H, Deng P, Ma YF, Wu Y, Ma ZH, Zhang W, et al. Advances in experimental and clinical research of the gouty arthritis treatment with Traditional Chinese Medicine. Evid Based Complement Altern Med. 2021;2021:8698232.
Yokose C, Mccormick N, Lu N, Joshi AD, Curhan G, Choi HK. Adherence to 2020 to 2025 dietary guidelines for Americans and the risk of new-onset female gout. JAMA Intern Med. 2022;182:254–64.
Seifi N, Bahari H, Nosrati M, Koochakpoor G, Alizadeh Hassani Z, Rastegarmoghadam-Ebrahimian A, et al. Higher dietary acid load is associated with the risk of hyperuricemia. Int Urol Nephrol. 2024;56:1743–9.
Article CAS PubMed Google Scholar
Krata AA, Domagala J, Glowacki R. Hydrophilic interaction liquid chromatography based method for simultaneous determination of purines and their derivatives in food spices. Food Chem. 2024;441:138285.
Article CAS PubMed Google Scholar
Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med. 2004;350:1093–103.
Article CAS PubMed Google Scholar
Dong YF, Sun N, Ge Q, Lv RZ, Lin SY. Antioxidant soy peptide can inhibit xanthine oxidase activity and improve LO2 cell damage. Food Biosci. 2023;52:102455.
Zhang C, Li L, Zhang Y, Zeng C. Recent advances in fructose intake and risk of hyperuricemia. Biomed Pharmacother. 2020;131:110795.
Article CAS PubMed Google Scholar
Helget LN, Mikuls TR. Environmental triggers of hyperuricemia and gout. Rheum Dis Clin North Am. 2022;48:891–906.
Article PubMed PubMed Central Google Scholar
Zhan X, He M, Pei J, Fan W, Mwangi CN, Zhang P, et al. Natural phenylethanoid supplementation alleviates metabolic syndrome in female mice induced by high-fructose diet. Front Pharmacol. 2022;13:850777.
Article CAS PubMed PubMed Central Google Scholar
Chen Y, Liu Q, Meng X, Zhao L, Zheng X, Feng W. Catalpol ameliorates fructose-induced renal inflammation by inhibiting TLR4/MyD88 signaling and uric acid reabsorption. Eur J Pharmacol. 2024;967:176356.
Article CAS PubMed Google Scholar
Yang Y, Zheng S, Feng Y. Associations between vitamin C intake and serum uric acid in US adults: findings from national health and nutrition examination survey 2011–2016. PLoS One. 2023;18:e0287352.
Article CAS PubMed PubMed Central Google Scholar
Bang M, Heo Y, Choi TK, Lee SH. Positive effects of uric acid on white matter microstructures and treatment response in patients with schizophrenia. Schizophr Bull. 2024;50:815–26.
Sandoval-Plata G, Nakafero G, Chakravorty M, Morgan K, Abhishek A. Association between serum urate, gout and comorbidities: a case-control study using data from the UK Biobank. Rheumatology. 2021;60:3243–51.
Liu S, Sun H, Yang S, Liang N, Gao Y, Qu S, et al. Clustering of gout-related comorbidities and their relationship with gout flares: a data-driven cluster analysis of eight comorbidities. J Endocrinol Invest. 2024;47:1119–28.
Article CAS PubMed Google Scholar
Yokose C, Mccormick N, Abhishek A, Dalbeth N, Pascart T, Liote F, et al. The clinical benefits of sodium-glucose cotransporter type 2 inhibitors in people with gout. Nat Rev Rheumatol. 2024;20:216–31.
Article CAS PubMed Google Scholar
Macay AL, Flores KM, Fernández-Torres J, Zamudio Y, Muñoz FS, Clavijo-Cornejo D. Gene expression of Abcg2, Alpk1, Slc22a12 and Il-1β in peripheral blood leukocytes of gout patients were correlated with their comorbidities and hyperuricemia. Ann Rheum Dis. 2023;82:1191–2.
Xu Z, Tao L, Su H. The complement system in metabolic-associated kidney diseases. Front Immunol. 2022;13:902063.
Article CAS PubMed PubMed Central Google Scholar
Gherghina ME, Peride I, Tiglis M, Neagu TP, Niculae A, Checherita IA. Uric acid and oxidative stress-relationship with cardiovascular, metabolic, and renal impairment. Int J Mol Sci. 2022;23:3188.
Liang N, Wu M, Gao Y, Yang S, Lin X, Sun H, et al. Purine metabolic pathway alterations and serum urate changes after oral inosine loading in male Chinese volunteers. Mol Nutr Food Res. 2024;68:e2300115.
Pang L, Liang N, Li C, Merriman TR, Zhang H, Yan F, et al. A stable liver-specific urate oxidase gene knockout hyperuricemia mouse model finds activated hepatic de novo purine biosynthesis and urate nephropathy. Biochim Biophys Acta Mol Basis Dis. 2024;1870:167009.
Article CAS PubMed Google Scholar
Lopez JM, Outtrim EL, Fu R, Sutcliffe DJ, Torres RJ, Jinnah HA. Physiological levels of folic acid reveal purine alterations in Lesch-Nyhan disease. Proc Natl Acad Sci USA. 2020;117:12071–9.
Article CAS PubMed PubMed Central Google Scholar
Gulati HK, Khanna A, Kumar N, Sharma A, Rupali, Jyoti, et al. Triazole derivatives as potential xanthine oxidase inhibitors: design, enzyme inhibition potential, and docking studies. Arch Pharmacol. 2024;357:e2300296.
Xie H, Hu N, Pan T, Wu JC, Yu M, Wang DC. Effectiveness and safety of different doses of febuxostat compared with allopurinol in the treatment of hyperuricemia: a meta-analysis of randomized controlled trials. BMC Pharmacol Toxicol. 2023;24:79.
Article CAS PubMed PubMed Central Google Scholar
Xing Z, Zhang F, Gao M, Xu Z, Liu Y, Shen G. Effect and mechanism of Rhein-praseodymium complex on intestinal uric acid excretion in rats with renal injury and hyperuricemia. Curr Med Chem. 2024. https://doi.org/10.2174/0109298673268642231214061615.
Yin H, Liu N, Chen J. The role of the intestine in the development of hyperuricemia. Front Immunol. 2022;13:845684.
Article CAS PubMed PubMed Central Google Scholar
Mandal AK, Mount DB. The molecular physiology of uric acid homeostasis. Annu Rev Physiol. 2015;77:323–45.
Article CAS PubMed Google Scholar
Li L, Zhang Y, Zeng C. Update on the epidemiology, genetics, and therapeutic options of hyperuricemia. Am J Transl Res. 2020;12:3167–81.
留言 (0)